Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
63
MET Quote, Financials, Valuation and Earnings
Last price:
$81.09
Seasonality move
:
0.34%
Day range:
$81.10 - $82.11
52-week range:
$65.21 - $88.09
Dividend yield:
2.76%
P/E ratio:
15.32x
P/S ratio:
0.77x
P/B ratio:
1.85x
Volume:
2.4M
Avg. volume:
3.8M
1-year change:
-0.01%
Market cap:
$53.6B
Revenue:
$71B
EPS (TTM):
$5.31
Analysts' Opinion
-
Consensus RatingMetLife, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $93.60, MetLife, Inc. has an estimated upside of 14.9% from its current price of $81.35.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $75.00 representing 7.81% downside risk from its current price of $81.35.
Fair Value
-
According to the consensus of 14 analysts, MetLife, Inc. has 14.9% upside to fair value with a price target of $93.60 per share.
MET vs. S&P 500
-
Over the past 5 trading days, MetLife, Inc. has underperformed the S&P 500 by -3.77% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
MetLife, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
MetLife, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter MetLife, Inc. reported revenues of $17.4B.
Earnings Growth
-
MetLife, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter MetLife, Inc. reported earnings per share of $1.22.
Enterprise value:
74.1B
EV / Invested capital:
1.50x
Price / LTM sales:
0.77x
EV / EBIT:
15.04x
EV / Revenue:
1.03x
PEG ratio (5yr expected):
2.15x
EV / Free cash flow:
4.89x
Price / Operating cash flow:
3.66x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.55%
Net Income Margin (TTM):
5.37%
Return On Equity:
13.43%
Return On Invested Capital:
7.96%
Operating Margin:
8.53%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $63.5B | $71.3B | $71.9B | $18.4B | $17.4B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | $4.3B | $6.2B | $6B | $2.3B | $1.5B | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $3.02 | $4.96 | $5.31 | $1.81 | $1.22 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $56B | $56B | $53.6B | $73.2B | $84.1B | |
| Total Assets | $761.7B | $650.1B | $652.1B | $705B | $719.7B | |
| Current Liabilities | $31.8B | $25.1B | $18B | $17.5B | $17.6B | |
| Total Liabilities | $692.3B | $624.8B | $626.2B | $673.8B | $690.5B | |
| Total Equity | $69.3B | $25.3B | $25.9B | $31.2B | $29.2B | |
| Total Debt | $18B | $18.4B | $19.3B | $19B | $19.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $9.2B | $15.7B | $15.1B | $4.2B | $3.6B | |
| Cash From Investing | -$11B | -$5.6B | -$16.7B | -$2.2B | -$5B | |
| Cash From Financing | -$7.2B | -$2.8B | $642M | -$1.1B | -$508M | |
| Free Cash Flow | $9.2B | $15.7B | $15.1B | $4.2B | $3.6B | |
MET
Sector
Market Cap
$53.6B
$565.4M
Price % of 52-Week High
92.35%
92.48%
Dividend Yield
2.76%
1.57%
Shareholder Yield
9.25%
3.12%
1-Year Price Total Return
-0.01%
8.05%
Beta (5-Year)
0.763
0.478
Dividend yield:
2.76%
Annualized payout:
$2.16
Payout ratio:
46.42%
Growth streak:
12 years
Technicals
8-day SMA
Sell
Level
$82.06
200-day SMA
Buy
Level
$78.53
Bollinger Bands (100)
Buy
Level
76.7 - 81.42
Chaikin Money Flow
Buy
Level
1.1B
20-day SMA
Buy
Level
$79.14
Relative Strength Index (RSI14)
Buy
Level
60.28
ADX Line
Buy
Level
22.87
Williams %R
Neutral
Level
-32.4254
50-day SMA
Buy
Level
$78.60
MACD (12, 26)
Buy
Level
1.20
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
885.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.3647)
Sell
CA Score
(Annual)
Level (-2.4903)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (4)
Buy
Ohlson Score
Level (0.3207)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
MetLife, Inc. engages in providing insurance and financial services to individual and institutional customers. It operates through the following segments: Group Benefits, Retirement and Income Solutions (RIS), Asia, MetLife Holdings, and Corporate and Other. The Group Benefits segment offers group life insurance products with renewable term policies. The RIS segment contains short and long-duration products, including capital market products, pension risk transfers, structured settlements, and other benefit funding products. The Asia segment focuses on Japan only and offers traditional life insurance, and accident and health products. The MetLife Holdings segment includes traditional and universal life products. The Corporate and Other segment refers to surplus investment portfolios used to fund capital and liquidity needs. The company was founded on March 24, 1868 and is headquartered in New York, NY.
Stock Forecast FAQ
In the current month, MET has received 9 Buy ratings 5 Hold ratings, and 0 Sell ratings. The MET average analyst price target in the past 3 months is $93.60.
-
Where Will MetLife, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that MetLife, Inc. share price will rise to $93.60 per share over the next 12 months.
-
What Do Analysts Say About MetLife, Inc.?
Analysts are divided on their view about MetLife, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MetLife, Inc. is a Sell and believe this share price will drop from its current level to $75.00.
-
What Is MetLife, Inc.'s Price Target?
The price target for MetLife, Inc. over the next 1-year time period is forecast to be $93.60 according to 14 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is MET A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for MetLife, Inc. is a Buy. 9 of 14 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MET?
You can purchase shares of MetLife, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MetLife, Inc. shares.
-
What Is The MetLife, Inc. Share Price Today?
MetLife, Inc. was last trading at $81.09 per share. This represents the most recent stock quote for MetLife, Inc.. Yesterday, MetLife, Inc. closed at $81.35 per share.
-
How To Buy MetLife, Inc. Stock Online?
In order to purchase MetLife, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MET Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MET
Sector
P/E ratio
15.32x
12.25x
PEG ratio
2.15x
0.31x
P/B ratio
1.85x
1.12x
Price / LTM sales
0.77x
1.85x
Growth Metrics
MET
Sector
Revenue growth
-5.85%
5.54%
Earnings growth
-32.53%
14.85%
Revenue (5-year growth)
0.39%
8.85%
Earnings forecast
$2.32
$0.62
Profitability
MET
Sector
Profitability FY 2024
--
--
Return on invested capital
7.96%
5.01%
Return on assets
0.55%
1.01%
Return on equity
13.43%
9.68%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
4
Balance Sheet
MET
Sector
Total cash
$112.7B
$431.4M
Short term investments
$80.5B
$211.3M
Total assets
$677.5B
$3.1B
Long term debt
$19.9B
$79.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 4.51% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is up 0.04% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is down 0.54% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
